Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression
Year: 2015
Type: article
Study design: Observational Study
Abstract: The myelodysplastic syndromes (MDS) are clonal disorders of the hematopoietic stem cell, characterized by ineffective hematopoiesis and peripheral blood cytopenias, and patients typically have a hypercellular bone marrow. Approximately 30–40% of patients undergo leukemic transformation to acute myeloid leukemia (AML) during the course of their disease. 1 Several recurrent gene mutations have been identified in MDS using next-generation sequencing (NGS), and recent studies have greatly illuminated the molecular landscape of this disorder. 2 , 3 , 4 However, the molecular events driving MDS progression to AML remain poorly understood.
Source: Leukemia
DOI: 10.1038/leu.2015.129
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,068
OpenAlex ID: W835691338
